vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and ENCORE CAPITAL GROUP INC (ECPG). Click either name above to swap in a different company.
ENCORE CAPITAL GROUP INC is the larger business by last-quarter revenue ($473.6M vs $359.9M, roughly 1.3× AdvanSix Inc.). ENCORE CAPITAL GROUP INC runs the higher net margin — 16.2% vs -0.8%, a 17.0% gap on every dollar of revenue. On growth, ENCORE CAPITAL GROUP INC posted the faster year-over-year revenue change (78.3% vs 9.4%). ENCORE CAPITAL GROUP INC produced more free cash flow last quarter ($126.9M vs $36.1M). Over the past eight quarters, ENCORE CAPITAL GROUP INC's revenue compounded faster (20.1% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
Encore Capital Group, Inc. is a publicly traded debt buyer based in the United States. The company is headquartered in San Diego, and operates throughout the United States. The firm is a publicly traded NASDAQ Global Select company (ECPG), a component stock of the Russell 2000, the S&P SmallCap 600, and the Wilshire 4500.
ASIX vs ECPG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $473.6M |
| Net Profit | $-2.8M | $76.7M |
| Gross Margin | 7.6% | — |
| Operating Margin | -0.7% | 36.6% |
| Net Margin | -0.8% | 16.2% |
| Revenue YoY | 9.4% | 78.3% |
| Net Profit YoY | -892.9% | — |
| EPS (diluted) | $-0.11 | $3.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $473.6M | ||
| Q3 25 | $374.5M | $460.4M | ||
| Q2 25 | $410.0M | $442.1M | ||
| Q1 25 | $377.8M | $392.8M | ||
| Q4 24 | $329.1M | $265.6M | ||
| Q3 24 | $398.2M | $367.1M | ||
| Q2 24 | $453.5M | $355.3M | ||
| Q1 24 | $336.8M | $328.4M |
| Q4 25 | $-2.8M | $76.7M | ||
| Q3 25 | $-2.6M | $74.7M | ||
| Q2 25 | $31.4M | $58.7M | ||
| Q1 25 | $23.3M | $46.8M | ||
| Q4 24 | $352.0K | — | ||
| Q3 24 | $22.3M | $30.6M | ||
| Q2 24 | $38.9M | $32.2M | ||
| Q1 24 | $-17.4M | $23.2M |
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 14.3% | — | ||
| Q1 25 | 14.2% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 17.9% | — | ||
| Q1 24 | 0.9% | — |
| Q4 25 | -0.7% | 36.6% | ||
| Q3 25 | -0.9% | 37.6% | ||
| Q2 25 | 7.7% | 34.1% | ||
| Q1 25 | 7.7% | 32.9% | ||
| Q4 24 | -3.9% | — | ||
| Q3 24 | 7.5% | 28.9% | ||
| Q2 24 | 11.5% | 28.7% | ||
| Q1 24 | -7.0% | 25.5% |
| Q4 25 | -0.8% | 16.2% | ||
| Q3 25 | -0.7% | 16.2% | ||
| Q2 25 | 7.7% | 13.3% | ||
| Q1 25 | 6.2% | 11.9% | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 5.6% | 8.3% | ||
| Q2 24 | 8.6% | 9.1% | ||
| Q1 24 | -5.2% | 7.1% |
| Q4 25 | $-0.11 | $3.32 | ||
| Q3 25 | $-0.10 | $3.17 | ||
| Q2 25 | $1.15 | $2.49 | ||
| Q1 25 | $0.86 | $1.93 | ||
| Q4 24 | $0.02 | — | ||
| Q3 24 | $0.82 | $1.26 | ||
| Q2 24 | $1.43 | $1.34 | ||
| Q1 24 | $-0.65 | $0.95 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $156.8M |
| Total DebtLower is stronger | — | $4.0B |
| Stockholders' EquityBook value | $815.2M | $976.8M |
| Total Assets | $1.7B | $5.3B |
| Debt / EquityLower = less leverage | — | 4.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | $156.8M | ||
| Q3 25 | $23.7M | $172.5M | ||
| Q2 25 | $18.4M | $172.9M | ||
| Q1 25 | $8.3M | $187.1M | ||
| Q4 24 | $19.6M | $199.9M | ||
| Q3 24 | $17.3M | $247.4M | ||
| Q2 24 | $12.1M | $250.6M | ||
| Q1 24 | $20.6M | $173.0M |
| Q4 25 | — | $4.0B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $3.7B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $815.2M | $976.8M | ||
| Q3 25 | $818.2M | $952.9M | ||
| Q2 25 | $823.7M | $896.0M | ||
| Q1 25 | $794.4M | $819.1M | ||
| Q4 24 | $774.6M | $767.3M | ||
| Q3 24 | $766.4M | $1.0B | ||
| Q2 24 | $746.6M | $988.1M | ||
| Q1 24 | $713.2M | $953.9M |
| Q4 25 | $1.7B | $5.3B | ||
| Q3 25 | $1.7B | $5.3B | ||
| Q2 25 | $1.6B | $5.2B | ||
| Q1 25 | $1.6B | $5.0B | ||
| Q4 24 | $1.6B | $4.8B | ||
| Q3 24 | $1.5B | $5.0B | ||
| Q2 24 | $1.5B | $4.8B | ||
| Q1 24 | $1.5B | $4.7B |
| Q4 25 | — | 4.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 4.83× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $153.2M |
| Free Cash FlowOCF − Capex | $36.1M | $126.9M |
| FCF MarginFCF / Revenue | 10.0% | 26.8% |
| Capex IntensityCapex / Revenue | 7.7% | 5.5% |
| Cash ConversionOCF / Net Profit | — | 2.00× |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $244.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $153.2M | ||
| Q3 25 | $26.6M | $81.6M | ||
| Q2 25 | $21.1M | $9.5M | ||
| Q1 25 | $11.4M | $45.3M | ||
| Q4 24 | $64.2M | $156.2M | ||
| Q3 24 | $57.3M | $45.9M | ||
| Q2 24 | $50.2M | $35.7M | ||
| Q1 24 | $-36.2M | $51.0M |
| Q4 25 | $36.1M | $126.9M | ||
| Q3 25 | $66.0K | $75.6M | ||
| Q2 25 | $-7.2M | $3.2M | ||
| Q1 25 | $-22.6M | $38.3M | ||
| Q4 24 | $29.8M | $127.2M | ||
| Q3 24 | $26.8M | $39.7M | ||
| Q2 24 | $16.7M | $28.3M | ||
| Q1 24 | $-71.6M | $44.1M |
| Q4 25 | 10.0% | 26.8% | ||
| Q3 25 | 0.0% | 16.4% | ||
| Q2 25 | -1.7% | 0.7% | ||
| Q1 25 | -6.0% | 9.7% | ||
| Q4 24 | 9.1% | 47.9% | ||
| Q3 24 | 6.7% | 10.8% | ||
| Q2 24 | 3.7% | 8.0% | ||
| Q1 24 | -21.3% | 13.4% |
| Q4 25 | 7.7% | 5.5% | ||
| Q3 25 | 7.1% | 1.3% | ||
| Q2 25 | 6.9% | 1.4% | ||
| Q1 25 | 9.0% | 1.8% | ||
| Q4 24 | 10.4% | 10.9% | ||
| Q3 24 | 7.7% | 1.7% | ||
| Q2 24 | 7.4% | 2.1% | ||
| Q1 24 | 10.5% | 2.1% |
| Q4 25 | — | 2.00× | ||
| Q3 25 | — | 1.09× | ||
| Q2 25 | 0.67× | 0.16× | ||
| Q1 25 | 0.49× | 0.97× | ||
| Q4 24 | 182.29× | — | ||
| Q3 24 | 2.57× | 1.50× | ||
| Q2 24 | 1.29× | 1.11× | ||
| Q1 24 | — | 2.19× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
ECPG
Segment breakdown not available.
